Retatrutide, from Soma Pharmaceuticals , represents a promising advance in weight control . This unique drug combines GLP-1 signaling activity with gut-derived pathway activation , showing impressive efficacy in clinical studies for weight reduction . Experts believe this treatment may offer a ne